Showing results (861-870 of 7,535) with videos related to

Sort By:
Pageof 754
Molecular Pharmaceutics|December 6, 2011
Controlled release pulmonary administration of curcumin using swellable biocompatible microparticlesIbrahim M El-Sherbiny, Hugh D C Smyth
Molecular Pharmaceutics|December 3, 2011
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable routeRajesh Ravindran, Mithun Maji, Nahid Ali
Molecular Pharmaceutics|October 12, 2011
Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T cell responses and confers protective antitumor immunityBruna F M M Porchia, Mariana O Diniz, Francisco A M O Cariri, et al.
Molecular Pharmaceutics|October 7, 2011
Nanomedicine(s) under the microscopeRuth Duncan, Rogerio Gaspar
Molecular Pharmaceutics|October 11, 2011
Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effectAmitava Mitra, Filippos Kesisoglou, Martyn Beauchamp, et al.
Molecular Pharmaceutics|October 11, 2011
A mechanistic study of tumor-targeted corrole toxicityJae Youn Hwang, Jay Lubow, David Chu, et al.
Molecular Pharmaceutics|October 13, 2011
Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imigluceraseOlga Abian, Pilar Alfonso, Adrian Velazquez-Campoy, et al.
Molecular Pharmaceutics|October 22, 2011
Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic studyE D'Aurizio, P Sozio, L S Cerasa, et al.
Molecular Pharmaceutics|October 11, 2011
Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid IXiang Xue, Li-Kun Gong, Kazuya Maeda, et al.
Molecular Pharmaceutics|January 11, 2012
Critical characteristics for corticosteroid solution metered dose inhaler bioequivalenceC I Grainger, M Saunders, F Buttini, et al.
Pageof 754